Why Is BioVie (BIVI) Stock Down 63% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

BioVie stock is falling after its Phase 3 clinical trial of its Alzheimer’s treatment candidate failed to show statistical significance.

The post Why Is BioVie (BIVI) Stock Down 63% Today? appeared first on InvestorPlace.

• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors